InsidersTradesSigma
메타바이오메드: directors' dealings · South Korea · DART (FSS)
DART:company-9700d8KR·DART (FSS)Mcap 133.3Bn€
Explore the full directors' dealings record of 메타바이오메드, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Market capitalisation: €133.3bn. The latest transaction was reported on 27 April 2026 (Purchase). Among the most active insiders: 메타바이오메드. Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
€1,022
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
4020.00 €
Income statement
Revenue102.95 Bn€
Gross profit53.59 Bn€52% margin
Net income10.99 Bn€10.7% margin
Balance sheet & cash
Market cap133.26 Bn€
Total debt42.72 Bn€
Free Cash Flow−627.9 M€
Last declaration on 27 April 2026
Declarations0 total
No declarations found
0 of 0 declarations